Oncolytic virotherapy using herpes simplex virus: how far have we come?

Oncolytic virotherapy exploits the properties of human viruses to naturally cytolysis of cancer cells. The human pathogen herpes simplex virus (HSV) has proven particularly amenable for use in oncolytic virotherapy. The relative safety of HSV coupled with extensive knowledge on how HSV interacts wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sokolowski, Nicolas AS, Rizos, Helen, Diefenbach, Russell J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918397/
https://www.ncbi.nlm.nih.gov/pubmed/27512683
http://dx.doi.org/10.2147/OV.S66086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918397/
https://www.ncbi.nlm.nih.gov/pubmed/27512683
http://dx.doi.org/10.2147/OV.S66086

Ejemplares similares